Midodrine Hydrochloride Aspire 5 mg tablets

Licence status
Authorised: 16/09/2022
Active substances
Midodrine hydrochloride
Dosage Form
Tablet
Licence number
PA23142/008/002
Licence holder
Aspire Pharma (Malta) Limited

Product documents

Licence information

ATC code
C01CA17 midodrine
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
16/09/2022

Interchangeable information